Patents Assigned to DIAGNOSTIG LTD
  • Patent number: 10809260
    Abstract: A method of determining whether an individual is infected with mycobacteria. The method comprising the steps of (a) providing a system which comprises at least two different mycolic-acid derived antigens; (b) introducing a sample obtained from the individual into the system and into contact with each of the at least two different mycolic-acid derived antigens; and (c) detecting the presence or absence of the binding of a biomarker in the sample with each antigen in the system. The method may be particularly suitable for determining the presence or absence of a disease antibody indicative of infection with any disease caused by infection with mycobacteria, for example tuberculosis, leprosy, pulmonary disease, burili ulcer, Johne's disease and bovine tuberculosis. A kit and device are also described. The present invention may provide an over the counter device to allow individuals to check on a routine basis that they have normal immune responses.
    Type: Grant
    Filed: August 13, 2015
    Date of Patent: October 20, 2020
    Assignee: DIAGNOSTIG LTD
    Inventors: Mark Stephen Baird, Christopher David Gwenin, Vanessa Valerie Gwenin, Alison Jones
  • Patent number: 10782293
    Abstract: A method of determining whether an individual is infected with a mycobacterial disease, the method comprising: (a) providing a system which comprises an antigen; (b) contacting the system with a sample obtained from the individual; and (c) detecting the presence or absence of binding of a biomarker in the sample with the antigen; wherein the antigen is a mycolic acid wax ester derived antigen.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: September 22, 2020
    Assignee: DIAGNOSTIG LTD
    Inventors: Mark Stephen Baird, Christopher David Gwenin, Juma'a Raheem Najeem Al Dulayymi, Salam Ghafour Taher